Company: CMND
Filing Date: 2025-09-15
Form Type: POS AM
Source: 0001213900-25-087398
Chunk: 37

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-15
Form: POS AM
Chunk 37
---
 The January 2024 PIPE
Warrants are governed by New York law.

<div align='center'>24

PLAN OF DISTRIBUTION</div>

Each selling shareholder of the securities and
any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby
on the principal trading market of our common shares or any other stock exchange, market or trading facility on which the securities
are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling shareholder may use any one or more
of the following methods when selling securities:

| ● | ordinary brokerage transactions and transactions in                                                                            
 which the broker-dealer solicits purchasers;                                                                                   |
| ● | block trades in which the broker-dealer will attempt                                                                           
 to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
| ● | purchases by a broker-dealer as principal and resale                                                                           
 by the broker-dealer for its account;                                                                                          |
| ● | an exchange distribution in accordance with the rules                                                                          
 of the applicable exchange;                                                                                                    |
| ● | privately negotiated transactions;                                                                                             |
| ● | settlement of short sales;                                                                                                     |
| ● | in transactions through broker-dealers that agree with                                                                         
 the Selling Shareholders to sell a specified number of such securities at a stipulated price per security;                     |
| ● | through the writing or settlement of options or other                                                                          
 hedging transactions, whether through an options exchange or otherwise;                                                        |
| ● | a combination of any such methods of sale; or                                                                                  |
| ● | any other method permitted pursuant to applicable law.                                                                         |

The selling shareholders may also sell securities
under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.

Broker-dealers engaged by the selling shareholders
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling shareholders
(or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except
as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission
in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.

In connection with the sale